ST未名：11月17日召开董事会会议

Group 1 - ST Unimed (SZ 002581) announced on November 17 that its sixth board meeting was held via telecommunication to discuss the proposal for changing the accounting firm [1] - For the first half of 2025, ST Unimed's revenue is entirely derived from its pharmaceutical business segment, accounting for 100.0% [1] - As of the report date, ST Unimed has a market capitalization of 5.5 billion yuan [2]